GUTS — Fractyl Health Cashflow Statement
0.000.00%
Last trade - 00:00- $306.98m
- $260.09m
- $0.09m
Annual cashflow statement for Fractyl Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.5 | -38.7 | -46.5 | -77.1 | -68.7 |
| Depreciation | |||||
| Non-Cash Items | 2.14 | 2.89 | 1 | 33 | -7.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.51 | 1.71 | -1.24 | 0.989 | 9.59 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -31.1 | -33.5 | -46.2 | -42.8 | -65.5 |
| Capital Expenditures | -0.002 | -0.051 | -0.056 | -0.359 | -1.76 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.002 | -0.051 | -0.056 | -0.359 | -1.76 |
| Financing Cash Flow Items | — | — | — | -0.963 | -2.85 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 54.4 | 99.9 | 4.35 | 27.4 | 101 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.3 | 66.4 | -41.9 | -15.7 | 33.9 |